Evaluation of Improved Preparation Time to a Coverage in Patients With Acute Wounds by Use of VistaCare® Versus Dressings
NCT ID: NCT02963519
Last Updated: 2016-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2016-11-30
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Demonstrate that in patients with acute leg wounds with skin defect, VistaCare® accelerates the formation of a quality granulation tissue and reduces preparation time to a cover gesture.
Secondary objectives:
* Evaluate the success of hedging gesture
* Assess the quality of the bud by colorimetry
* Assess tolerance
* Collect medical and economic data on the care of patients included
* Evaluate the quality of life of patients
* Assess patient comfort
* Evaluate the ease of use for the caregiver
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VistaCare®
VistaCare® Medical device for treatment into an editable atmosphere
VistaCare®
Dressings
Dressings Adapted to the case
Dressings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VistaCare®
Dressings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 18 to 65 inclusive
* Patient with acute or leg sores (s), traumatic, with skin defect with or without external fixators and without exposure to fine fabrics (functional tendon, artery, vessel, bone, osteosynthesis material ...). These wounds may be burns, deep second degree only.
* Patient having no associated pathology
* Patient has given its written consent, lighting, dated and signed
* Patient affiliated to a social security scheme
* Voluntary Patient and able to comply with the protocol requirements
* Patient whose wound is located below the knee
* Patient whose wound date of less than 2 weeks
* A patient whose wound has a minimum area of 10 cm2
* Patient whose wound does not require surgical debridement after inclusion (if surgical debridement is necessary, it must be performed before inclusion in the study)
Exclusion Criteria
* Women of childbearing potential not using effective contraception (combined hormonal, IUD) and failing achieving a pregnancy test and getting the result before starting treatment
* Patients do not speak and do not read French
* Patient with one or more risk factors such as smoking more than 5 cigarettes a day, diabetes, autoimmune disease
* Patients with such treatment during or within one month prior to inclusion in the study: corticosteroids, topical corticosteroids at the immunosuppressive wound or radiotherapy
* A patient whose wound is located at a place not compatible with the use of VistaCare®
* Patient with traumatic wound leg with exposure to some tissues (functional tendon, artery, vessel, bone, osteosynthesis material ...)
* Patient with general signs of infection (temperature, lymphangitis, osteitis proven)
* Patient with a bleeding wound
* Patient with a burn to a stage other than deep second degree
* Patients with a wound whose area is less than 10 cm2
* Patient with a plague of nontraumatic leg
* Previous participation in this trial
* Patient in exclusion period from another clinical trial or participated in a clinical trial in the month before inclusion
* Patient whose wound is more than 2 weeks
* Patient whose wound was treated by hyperbaric chamber
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DTA Medical
UNKNOWN
Qualissima
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Casanova
Role: PRINCIPAL_INVESTIGATOR
APHM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Conception
Marseille, , France
CHU Nantes
Nantes, , France
Hôpital Saint Louis
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A00448-43
Identifier Type: -
Identifier Source: org_study_id